| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1681/ASN.2006050420 |
| P698 | PubMed publication ID | 17035610 |
| P2093 | author name string | Frank Strutz | |
| Michael Zeisberg | |||
| P2860 | cites work | Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities | Q28508460 |
| P433 | issue | 11 | |
| P304 | page(s) | 2992-2998 | |
| P577 | publication date | 2006-10-11 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Renal fibroblasts and myofibroblasts in chronic kidney disease | |
| P478 | volume | 17 |
| Q34870775 | A2B adenosine receptor-mediated induction of IL-6 promotes CKD. |
| Q57716784 | Acute and chronic effects of metabolic acidosis on renal function and structure |
| Q41648550 | Administration of α-Galactosylceramide Improves Adenine-Induced Renal Injury |
| Q51193055 | Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin. |
| Q42516850 | An immunofluorescence assay for extracellular matrix components highlights the role of epithelial cells in producing a stable, fibrillar extracellular matrix |
| Q89138125 | Antifibrotic role of PGC-1α-siRNA against TGF-β1-induced renal interstitial fibrosis |
| Q90707336 | Arsenic trioxide and curcumin attenuate cisplatin-induced renal fibrosis in rats through targeting Hedgehog signaling |
| Q42963130 | Asiatic acid ameliorates tubulointerstitial fibrosis in mice with ureteral obstruction |
| Q34837833 | Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy |
| Q35994934 | Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice |
| Q58108235 | Biomarker Profiling in Stage 5 Chronic Kidney Disease Identifies the Relationship between Angiopoietin-2 and Atrial Fibrillation |
| Q34263666 | Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis. |
| Q38410868 | CD248+ stromal cells are associated with progressive chronic kidney disease. |
| Q49550567 | CERA Attenuates Kidney Fibrogenesis in the db/db Mouse by Influencing the Renal Myofibroblast Generation |
| Q64055054 | CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway |
| Q58101680 | Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression |
| Q37703469 | Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis |
| Q35903772 | Cellular and molecular mechanisms of renal fibrosis |
| Q51734994 | Characterisation of feline renal cortical fibroblast cultures and their transcriptional response to transforming growth factor β1. |
| Q106957867 | Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets |
| Q35138504 | Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors |
| Q55074385 | Combination therapy of chitosan, gynostemma, and motherwort alleviates the progression of experimental rat chronic renal failure by inhibiting STAT1 activation. |
| Q35370283 | Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation |
| Q35228505 | Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD |
| Q46247002 | Deletion of the alpha8 integrin gene does not protect mice from myocardial fibrosis in DOCA hypertension |
| Q39218625 | Developmental origins and functions of stromal cells in the normal and diseased mammalian kidney |
| Q37349206 | Diabetes and Kidney Disease: Role of Oxidative Stress |
| Q34237738 | Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model |
| Q36589609 | Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis |
| Q38810830 | Dietary low-fat soy milk powder retards diabetic nephropathy progression via inhibition of renal fibrosis and renal inflammation. |
| Q26766089 | Dipeptidyl peptidase-4 and kidney fibrosis in diabetes |
| Q28508395 | Disruption of the Dapper3 gene aggravates ureteral obstruction-mediated renal fibrosis by amplifying Wnt/β-catenin signaling |
| Q43890254 | Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts |
| Q28555194 | Downregulation of TGF-β Receptor-2 Expression and Signaling through Inhibition of Na/K-ATPase |
| Q37248336 | EMT and proteinuria as progression factors |
| Q53814834 | Effects of T lymphocytes, interleukin-1, and interleukin-6 on renal fibrosis in canine end-stage renal disease. |
| Q41905147 | Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease |
| Q38746021 | Elucidation of the therapeutic role of mitochondrial biogenesis transducers NRF-1 in the regulation of renal fibrosis |
| Q91867313 | Emerging Roles for NLRC5 in Immune Diseases |
| Q43697611 | Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway |
| Q36559707 | Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria |
| Q35903075 | Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis |
| Q28066669 | Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis |
| Q53118344 | Expression of TNFRSF6B in kidneys is a novel predictor for progression of chronic kidney disease. |
| Q41846598 | Expression of nestin, vimentin, and NCAM by renal interstitial cells after ischemic tubular injury |
| Q47325241 | FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy |
| Q37498285 | Fibroblast activation and myofibroblast generation in obstructive nephropathy |
| Q91884184 | Fibroblast-specific plasminogen activator inhibitor-1 depletion ameliorates renal interstitial fibrosis after unilateral ureteral obstruction |
| Q36985824 | Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition |
| Q36818891 | Fibrocytes: a new insight into kidney fibrosis |
| Q26801150 | Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family |
| Q33672045 | Follistatin like-1 aggravates silica-induced mouse lung injury |
| Q36187612 | Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage |
| Q39472497 | Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells |
| Q35923493 | Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice |
| Q91993884 | Health Benefits of Resveratrol in Kidney Disease: Evidence from In Vitro and In Vivo Studies |
| Q46134162 | Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy |
| Q52861093 | Human biliary tree stem/progenitor cells immunomodulation: Role of hepatocyte growth factor. |
| Q33924416 | Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. |
| Q34719308 | Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. |
| Q35723477 | Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis |
| Q48823999 | Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis |
| Q37330584 | Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis |
| Q33722323 | Instructive Role of the Microenvironment in Preventing Renal Fibrosis |
| Q37688040 | Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice. |
| Q35859758 | Interstitial pericytes decrease in aged mouse kidneys |
| Q37820315 | Involvement of bone-marrow-derived cells in kidney fibrosis |
| Q47316195 | Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1. |
| Q38965213 | Klotho suppresses renal tubulo-interstitial fibrosis by controlling basic fibroblast growth factor-2 signalling |
| Q34338572 | L-Endoglin overexpression increases renal fibrosis after unilateral ureteral obstruction. |
| Q34835060 | LRP-1: functions, signaling and implications in kidney and other diseases |
| Q54441251 | Lefty A attenuates the TGF-beta1-induced epithelial to mesenchymal transition of human renal proximal epithelial tubular cells. |
| Q34314334 | Mathematical model of renal interstitial fibrosis |
| Q35019643 | Methylation determines fibroblast activation and fibrogenesis in the kidney |
| Q37678211 | MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice |
| Q36536375 | MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy |
| Q92252739 | MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells |
| Q36637619 | MnTBAP Therapy Attenuates Renal Fibrosis in Mice with 5/6 Nephrectomy |
| Q39587424 | Monocytes induce proximal tubular epithelial-mesenchymal transition through NF-kappa B dependent upregulation of ICAM-1. |
| Q27008887 | N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes |
| Q42459552 | Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells. |
| Q37115034 | Novel actions of tissue-type plasminogen activator in chronic kidney disease |
| Q37283558 | Obstructive renal injury: from fluid mechanics to molecular cell biology |
| Q59813551 | Osthole Ameliorates Renal Fibrosis in Mice by Suppressing Fibroblast Activation and Epithelial-Mesenchymal Transition |
| Q42186528 | Overexpression of Delayed Rectifier K(+) Channels Promotes In situ Proliferation of Leukocytes in Rat Kidneys with Advanced Chronic Renal Failure |
| Q38237328 | Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease |
| Q28554628 | Piceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK Signaling |
| Q43083167 | Potassium channels, renal fibrosis, and diabetes |
| Q80501260 | Potential role of fractalkine receptor expression in human renal fibrogenesis |
| Q52893848 | Precision-cut human kidney slices as a model to elucidate the process of renal fibrosis. |
| Q41839678 | Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo |
| Q33745126 | Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3. |
| Q36865472 | Protection of rhein on IgA nephropathy mediated by inhibition of fibronectin expression in rats |
| Q36135728 | QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin |
| Q49823600 | Qingxuan Jiangya Decoction Mitigates Renal Interstitial Fibrosis in Spontaneously Hypertensive Rats by Regulating Transforming Growth Factor-β1/Smad Signaling Pathway |
| Q34217419 | Rapamycin ameliorates kidney fibrosis by inhibiting the activation of mTOR signaling in interstitial macrophages and myofibroblasts |
| Q39303904 | Recent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis |
| Q34289498 | Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation |
| Q36138680 | Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury |
| Q36314969 | Renal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure |
| Q27021975 | Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury |
| Q37305118 | Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels |
| Q44655473 | Renal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis. |
| Q26863552 | Renal pericytes: regulators of medullary blood flow |
| Q46131293 | Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway |
| Q37108009 | Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease |
| Q42742727 | Role of 6-O-sulfated heparan sulfate in chronic renal fibrosis. |
| Q46091769 | Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts |
| Q39352236 | Role of complement 3 in TNF-α-induced mesenchymal transition of renal tubular epithelial cells in vitro |
| Q38223110 | Role of the potassium channel KCa3.1 in diabetic nephropathy |
| Q37220474 | S-Fas urinary excretion helps to predict the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis |
| Q37856705 | Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition |
| Q54190117 | Study on lead-induced activation of rat renal interstitial fibroblasts and the related mechanisms. |
| Q36986519 | Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury |
| Q38724337 | TGF-β: the connecting link between nephropathy and fibrosis |
| Q39418101 | TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition |
| Q34124196 | TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury |
| Q60915176 | TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions |
| Q47817742 | The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis |
| Q34665751 | The T-box transcription factor Brachyury promotes renal interstitial fibrosis by repressing E-cadherin expression |
| Q39148597 | The antifibrotic effect of a serine protease inhibitor in the kidney |
| Q38224257 | The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis |
| Q33570124 | The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria |
| Q39175631 | The molecular biology of pelvi-ureteric junction obstruction |
| Q38172403 | The physical basis of renal fibrosis: effects of altered hydrodynamic forces on kidney homeostasis |
| Q33455868 | The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury |
| Q38273688 | The role of endoglin in kidney fibrosis |
| Q38246646 | The role of pericyte detachment in vascular rarefaction |
| Q38055432 | The role of promoter hypermethylation in fibroblast activation and fibrogenesis |
| Q52688968 | The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin. |
| Q45337590 | Thymoquinone protects the rat kidneys against renal fibrosis |
| Q36151652 | Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling |
| Q38753764 | Treatment with cytokine thymic stromal lymphopoietin short hairpin RNA substantially reduces TGF-β1-induced interstitial cellular fibrosis |
| Q38144939 | Unilateral ureteral obstruction: beyond obstruction. |
| Q55476540 | Upregulation of allograft inflammatory factor‑1 expression and secretion by macrophages stimulated with aldosterone promotes renal fibroblasts to a profibrotic phenotype. |
| Q47853012 | Urinary tract obstruction in the mouse: the kinetics of distal nephron injury. |
| Q52815575 | Valproic acid attenuates renal fibrosis through the induction of autophagy. |
| Q35761143 | Variable Expression of Neural Cell Adhesion Molecule Isoforms in Renal Tissue: Possible Role in Incipient Renal Fibrosis |
| Q100316356 | WNT-β-catenin signalling - a versatile player in kidney injury and repair |
| Q38789483 | c-Jun-N-Terminal Kinase Signaling Is Involved in Cyclosporine-Induced Epithelial Phenotypic Changes |
| Q34162322 | tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway |
| Q28564568 | tPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signaling |
| Q34736911 | tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis |
Search more.